GLSI - Greenwich LifeSciences, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
13,468
27,204
28,660
6.835
Total Cash
13,468
27,204
28,660
6.835
Total Current Assets
13,468
27,204
28,660
6.835
Non-current assets
Intangible Assets
9.003
12.615
16.227
19.836
Total non-current assets
9.003
12.615
16.227
19.836
Total Assets
13,477
27,217
28,677
26.671
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Accounts Payable
220.845
220.845
710.971
730.309
Accrued liabilities
262.905
385.172
770.338
741.935
Total Current Liabilities
262.905
385.172
1,045
1,377
Non-current liabilities
Total non-current liabilities
0
0
0
0
Total Liabilities
262.905
385.172
1,045
1,377
Stockholders' Equity
Common Stock
12.848
13.148
12.704
10.439
Retained Earnings
-41,473
-33,648
-29,077
-27,214
Total stockholders' equity
13,214
26,832
27,631
-1,350
Total liabilities and stockholders' equity
13,477
27,217
28,677
26.671